Document is current
Any future updates will be listed below
-
Authors
Yeboa, Debra Nana
Whitfield, Benjamin T.
Lin, Ruitao
Ejezie, Chinenye Lynette
Swanson, Todd A.
Beckham, Thomas H.
Wang, Chenyang
De, Brian
Perni, Subha
Tom, Martin C.
Li, Jing
McGovern, Susan L.
Harrison, Rebecca
Majd, Nazanin K.
Puduvalli, Vinay K.
Aaroe, Ashley E.
Loghin, Monica
O’Brien, Barbara J.
Patel, Anuj D.
Patel, Chirag B.
Wefel, Jeffrey S.
Taslicay, Ceylan Altintas
Gule-Monroe, Maria
Paulino, Arnold C.
McAleer, Mary Frances
Grosshans, David R.
Ghia, Amol J.
Jiang, Wen
Chung, Caroline
Maor, Moshe
Yang, Cheng-Han
Gubbiotti, Maria A.
Kamiya-Matsuoka, Carlos
Ballester, Leomar Y.
Weathers, Shiao-Pei
Huse, Jason T.
-
Funding
Funding for this research was provided by:
MDACC CORE grant start up funds
- License Information
-
More Information
Article History
Received: 5 May 2025
Accepted: 17 September 2025
First Online: 5 November 2025
Declarations
:
: Dr. Harrison discloses: Consulting- Servier Canada, Novocure; Honorarium: Pfizer, EMD Serono. Dr. CB Patel discloses: McNair Scholar supported by the McNair Medical Institute at The Robert and Janice McNair Foundation. Dr. Weathers discloses: Genentech and Exelixis trial support for unrelated clinical trials. Dr. McGovern discloses: Chimerix Advisory Board.
: The authors declare no competing interests.
